Scientists finally solved how a common gut bacterium triggers colon cancer

Scientists have cracked the code on how a prevalent gut bacterium contributes to colon cancer by identifying the bacterial toxin's mechanism. This toxin latches onto a receptor called claudin-4, compromising the colon's protective barrier. Researchers have now devised a decoy protein that effectively thwarted the toxin in mice, which could lead to innovative treatments to curb inflammation and prevent colon tumors. This breakthrough could significantly impact cancer prevention strategies and offer hope for more effective therapies against colorectal cancer.